Perspectives of Phage-Eukaryotic Cell Interactions to Control Epstein-Barr Virus Infections

Area of Science:

• Microbiology
• Virology
• Immunology

Background:

• Growing global interest in bacteriophages (phages) for medical applications, particularly for antibiotic-resistant infections.
• Emerging research highlights phage interactions with eukaryotic cells, suggesting roles beyond bacterial lysis, including immune system modulation.
• Previous studies hinted at phages acting as a component of the body's defense system against pathogens.

Purpose of the Study:

• To review the current status and future perspectives of phage therapy for antibiotic-resistant infections.
• To discuss recent advancements in understanding phage-eukaryotic cell interactions and their immunological implications.
• To envision the application of expanded phage knowledge in combating herpesvirus infections, specifically Epstein-Barr virus (EBV).

Main Methods:

• Literature review of recent publications in leading medical and scientific journals.
• Analysis of research on phage interactions with immune cells.
• Exploration of potential therapeutic strategies for EBV utilizing phage advancements.

Main Results:

• Phage therapy is gaining traction for treating multidrug-resistant bacterial infections.
• Phages interact with host immune systems, suggesting a broader biological role.
• The expanding understanding of phages opens new avenues for viral infection treatment.

Conclusions:

• Phage therapy holds significant potential for treating challenging bacterial infections.
• Phages may play a crucial role in innate immunity and host defense.
• Further research into phage-host interactions could lead to novel treatments for viral diseases like EBV infections.